WELCOME TO THE MYOSITIS COMMUNITY: This Patient-To-Patient Community is for discussions relating to Myositis which is an inflammation of skeletal muscles, which are also called the voluntary muscles. These are the muscles you consciously control that help you move your body. An injury, infection or autoimmune disease can cause myositis.
For support and advice from others,
visit our Myositis
Community
Myositis is the
chronic inflammation of muscle tissue. The
inflammatory myopathies are a group of diseases that involve myositis, accompanied
by muscle weakness. The primary types of chronic myositis are polymyositis, dermatomyositis, and inclusion body myositis.
What
is Polymyositis?
Polymyositis is one of a group of
muscle diseases known as the inflammatory myopathies, which are characterized
by chronic muscle inflammation accompanied by muscle weakness.
Polymyositis affects skeletal muscles (those involved with making movement) on
both sides of the body. It is rarely seen in persons under age 18; most
cases are in adults between the ages of 31 and 60. Progressive muscle
weakness starts in the proximal muscles (muscles closest to the trunk of the
body) which eventually leads to difficulties climbing stairs, rising from a
seated position, lifting objects, or reaching overhead. People with
polymyositis may also experience arthritis, shortness of breath, difficulty
swallowing and speaking, and heart arrhythmias. In some cases of polymyositis,
distal muscles (muscles further away from the trunk of the body, such as those
in the forearms and around the ankles and wrists) may be affected as the
disease progresses. Polymyositis may be associated with collagen-vascular
or autoimmune diseases, such as lupus. Polymyositis may also be
associated with infectious disorders, such as HIV-AIDS.
Is
there any treatment?
There is no cure for polymyositis,
but the symptoms can be treated. Options include medication, physical
therapy, exercise, heat therapy (including microwave and ultrasound), orthotics
and assistive devices, and rest. The standard treatment for polymyositis
is a corticosteroid drug, given either in pill form or intravenously.
Immunosuppressant drugs, such as azathioprine and methotrexate, may reduce
inflammation in people who do not respond well to prednisone. Periodic
treatment using intravenous immunoglobulin can also improve recovery.
Other immunosuppressive agents used to treat the inflammation associated with
polymyositis include cyclosporine A, cyclophosphamide, and tacrolimus.
Physical therapy is usually recommended to prevent muscle atrophy and to regain
muscle strength and range of motion.
What
is the prognosis?
The prognosis for polymyositis
varies. Most people respond fairly well to therapy, but some have a more
severe disease that does not respond adequately to therapies and are left with
significant disability. In rare cases individuals with severe and
progressive muscle weakness will develop respiratory failure or
pneumonia. Difficulty swallowing may cause weight loss and
malnutrition.
What
research is being done?
The National Institute of
Neurological Disorders and Stroke (NINDS) and other institutes of the National
Institutes of Health (NIH) conduct research relating to polymyositis in
laboratories at the NIH and support additional research through grants to major
medical institutions across the country. Currently funded research is
exploring patterns of gene expression among the inflammatory myopathies, the
role of viral infection as a precursor to the disorders, and the safety and
efficacy of various treatment regimens.
Source: Information provided courtesy of the National Institute of Neurological Disorders and
Stroke (NINDS), a division of the National
Institutes of Health (NIH).
NINDS health-related material is
provided for information purposes only and does not necessarily represent
endorsement by or an official position of the National Institute of
Neurological Disorders and Stroke or any other Federal agency. Advice on the
treatment or care of an individual patient should be obtained through
consultation with a physician who has examined that patient or is familiar with
that patient's medical history.
o Myositis
o
Dermatomyositis
o
Inclusion Body Myositis